Third Rock Ventures GP III, L.P.
SEC CIK 1637300 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | 10% | 5.27M | — | $7.30M | 4 | 2022-08-12 | 2023-01-20 |
Most active insiders at VYGR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| 2 | Swartz Robin | COO, CBO | — | $55.3K |
| 3 | Jorgensen Nathan D. | CFO | — | $54.2K |
| 4 | Carter Todd Alfred | CSO | — | $40.6K |
| 5 | Shiferman Gregory L. | SVP, GC | — | — |
| 6 | Ferguson Toby | Chief Medical Off | — | — |
Third Rock Ventures GP III, L.P. made no open-market trades at VYGR in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-24 | 2023-01-20+ | VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures GP III, L.P. | 10% | S - Sale | $9.12 | -155.0K | 5.27M | -3% | -$1.41M |
| M | 2022-08-26 | 2022-08-24+ | VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures GP III, L.P. | 10% | S - Sale | $6.16 | -350.0K | 5.43M | -6% | -$2.16M |
| 2022-08-18 | 2022-08-16 | VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures GP III, L.P. | 10% | S - Sale | $6.04 | -128.5K | 5.78M | -2% | -$775.9K | |
| M | 2022-08-16 | 2022-08-12+ | VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures GP III, L.P. | 10% | S - Sale | $6.10 | -483.8K | 6.04M | -7% | -$2.95M |
Purchase Sale Sale after option exercise All abbreviations